SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rui Yu, Rong Fan, Jinlin Hou, Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China, Frontiers of Medicine, 2014, 8, 2, 135

    CrossRef

  2. 2
    Mo Bin Wan, Xin Hua Weng, Expert recommendations on the application of interferon for chronic hepatitis B, Journal of Digestive Diseases, 2013, 14, 12
  3. 3
    Hyung Joon Yim, Seong Gyu Hwang, Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade, Clinical and Molecular Hepatology, 2013, 19, 3, 195

    CrossRef

  4. 4
    Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, Pietro Lampertico, Massimo Colombo, PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history, Expert Review of Anti-infective Therapy, 2013, 11, 5, 459

    CrossRef

  5. 5
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  6. 6
    KASL Clinical Practice Guidelines: Management of chronic hepatitis B, Clinical and Molecular Hepatology, 2012, 18, 2, 109

    CrossRef

  7. 7
    Cheng Wang, Rong Fan, Jian Sun, Jinlin Hou, Prevention and management of drug resistant hepatitis B virus infections, Journal of Gastroenterology and Hepatology, 2012, 27, 9